Scientists, developers, and manufacturers working on new vaccines and treatments, scaling up production of approved drugs and advancing other projects to address COVID-19 can now access the United States Pharmacopeia-National Formulary (USP-NF) Online for free for 6 months.
USP-NF houses the most comprehensive source for medicine quality standards in the world. These include analytical methods, specifications, procedures, assays and other guidelines to assess product safety and quality. Companies and research groups can use these standards to get therapeutics to market more efficiently. They save time and resources from having to develop in-house processes.
Following USP public quality standards also provides confidence that products will meet regulatory requirements of the U.S. Food and Drug Administration and other regulators around the world that use USP-NF. Additionally, public quality standards build trust with healthcare practitioners and patients that is necessary for wide scale adoption of COVID-19 vaccines and treatments.
The resources in USP-NF can support:
- manufacturers addressing drug or raw material shortages;
- research organizations and pharmaceutical companies working on analytical methods to characterize or release a new vaccine or treatment;
- researchers, regulators, manufacturers and healthcare practitioners evaluating approved drugs for new indications related to COVID-19 treatments; and
- formulators sourcing or verifying ingredients (excipients) for use in dosage forms.
This offer is valid only for those who are not current subscribers to the USP-NF Online platform. The trial period begins once access is activated and ends the last day of the sixth month. Subscribers will have the opportunity to purchase a full subscription once the trial is over. Trial offers must be activated by August 30, 2020.
Complete the form and watch for an email within 2-3 business days with instructions to get started. Questions? Contact firstname.lastname@example.org.